Sustained and Subsequent Response to Atogepant Among Individuals With Chronic Migraine: Post Hoc Analysis of the PROGRESS Trial

被引：0
|
作者：
Lipton, R. [1 ]
Chalermpalanupap, N. [2 ]
Nahas-Geiger, S. [3 ]
Pozo-Rosich, P. [4 ]
McAllister, P. [5 ]
Tatsuoka, Y. [6 ]
Liu, Y. [7 ]
Dabruzzo, B. [2 ]
Smith, J. [7 ]
Bilchik, T. [8 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY USA
[2] AbbVie, Madison, NJ USA
[3] Thomas Jefferson Univ, Dept Neurol, Jefferson Headache Ctr, Philadelphia, PA USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
[5] New England Inst Neurol & Headache, Stamford, CT USA
[6] Tatsuoka Neurol Clin, Kyoto, Japan
[7] AbbVie, N Chicago, IL USA
[8] Yale Sch Med, New Haven, CT USA
来源：
HEADACHE | 2023年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-180
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [31] SUSTAINED CLINICAL BENEFITS FOLLOWING ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH CHRONIC MIGRAINE: A POST HOC ANALYSIS OF THE POOLED PREEMPT STUDIES
    Dodick, David W.
    Diener, Hans-Christoph
    Silberstein, Stephen D.
    Yedigarova, Larisa
    Lipton, Richard B.
    CEPHALALGIA, 2020, 40 : 92 - 93
  • [32] Sustained Clinical Benefits Following OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: A Post Hoc Analysis of the Pooled PREEMPT Studies
    Dodick, D. W.
    Diener, H.
    Silberstein, S. D.
    Yedigarova, L.
    Lipton, R. B.
    HEADACHE, 2020, 60 : 26 - 26
  • [33] Intravenous fluids for migraine: a post hoc analysis of clinical trial data
    Balbin, Jerome Edward B.
    Nerenberg, Rebecca
    Baratloo, Alireza
    Friedman, Benjamin W.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (04): : 713 - 716
  • [34] Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
    Rizzoli, Paul
    Marmura, Michael J.
    Robblee, Jennifer
    Mcvige, Jennifer
    Sacco, Sara
    Nahas, Stephanie J.
    Ailani, Jessica
    De Abreu Ferreira, Rosa
    Ma, Julia
    Smith, Jonathan H.
    Dabruzzo, Brett
    Ashina, Messoud
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [35] Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial
    Goadsby, Peter J.
    Friedman, Deborah I.
    Holle-Lee, Dagny
    Demarquay, Genevieve
    Ashina, Sait
    Sakai, Fumihiko
    Neel, Brian
    Gandhi, Pranav
    Dabruzzo, Brett
    Smith, Jonathan H.
    Liu, Yingyi
    Trugman, Joel M.
    NEUROLOGY, 2024, 103 (02)
  • [36] Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo- controlled, phase 3 trial
    Pozo-Rosich, Patricia
    Ailani, Jessica
    Ashina, Messoud
    Goadsby, Peter J.
    Lipton, Richard B.
    Reuter, Uwe
    Guo, Hua
    Schwefel, Brittany
    Lu, Kaifeng
    Boinpally, Ramesh
    Miceli, Rosa
    Ferreira, Rosa De Abreu
    Mccusker, Emily
    Yu, Sung Yun
    Severt, Lawrence
    Finnegan, Michelle
    Trugman, Joel M.
    LANCET, 2023, 402 (10404): : 775 - 785
  • [37] Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
    Patricia Pozo-Rosich
    Karen H. Samaan
    Todd J. Schwedt
    Robert A. Nicholson
    Mallikarjuna Rettiganti
    Eric M. Pearlman
    Advances in Therapy, 2021, 38 : 3154 - 3165
  • [38] Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
    Pozo-Rosich, Patricia
    Samaan, Karen H.
    Schwedt, Todd J.
    Nicholson, Robert A.
    Rettiganti, Mallikarjuna
    Pearlman, Eric M.
    ADVANCES IN THERAPY, 2021, 38 (06) : 3154 - 3165
  • [39] Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial
    Smeijer, J. David
    de Vries, Sieta T.
    Kohan, Donald E.
    Hou, Fan Fan
    Heerspink, Hiddo J. L.
    DIABETOLOGIA, 2025, 68 (03) : 516 - 525
  • [40] Responder Rates to OnabotulinumtoxinA in Patients With Chronic Migraine: A Post Hoc Analysis of the COMPEL Study
    Rothrock, John F.
    Luo, Lei
    Eross, Eric
    Sommer, Katherine
    Blumenfeld, Andrew M.
    NEUROLOGY, 2020, 94 (15)
12345